Status:
COMPLETED
Relational Agents in Cervical Cancer Education (RACE)
Lead Sponsor:
Radhika Gogoi
Collaborating Sponsors:
University of Oklahoma
Conditions:
Cervix Cancer
Human Papilloma Virus
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.
Eligibility Criteria
Inclusion
- Adults aged 18 and older
- Patients with an ICD9 diagnosis of cervical/vaginal/vulvar cancer or dysplasia receiving care at Karmanos Cancer Institute or OU Health Stephenson Cancer Center
Exclusion
- Patients who are recorded in the EHR as requesting to be removed from research
- Non-English speakers
- Any cognitive disability that prevents informed consent
- Any individual recruited in previous phases of the Study will be excluded.
Key Trial Info
Start Date :
November 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT06537687
Start Date
November 18 2020
End Date
July 31 2023
Last Update
August 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Karmanos Cancer Institute
Detroit, Michigan, United States, 48201
2
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104